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Fungemia caused by non-Candida speciesDear Editor,
We read with great interest the article in the Journal of
Microbiology, Immunology and Infection by Chi et al,1
reporting a retrospective study of 108 patients with
Candida species bloodstream infections at a hospital in
northern Taiwan. In that study, they concluded that the
outcome of candidemia was poor, with mortality of 44.3%
and 29.8% in C. albicans and non-albicans candidemia,
respectively. Although these findings of candidemia areTable 1 Clinical manifestation of 16 patients with non-Candida
Case Year Age Sex Underlying disease Fung
1 2005 40 F Nil Cryp
2 2005 44 M HIV infection Crypt
3 2005 67 F Lymphoma receiving
chemotherapy
Crypt
4 2006 68 M Hepatoma receiving
chemotherapy, liver cirrhosis
Crypt
5 2007 61 M Lymphoma receiving
chemotherapy
Crypt
6 2007 45 F Breast cancer receiving
chemotherapy
Crypt
7 2007 78 M HIV infection Crypt
8 2007 71 F Diabetes mellitus Crypt
9 2008 62 F Lymphoma receiving
chemotherapy
Crypt
10 2008 57 M Diabetes mellitus Crypt
11 2008 80 M Lung cancer receiving
chemotherapy, liver cirrhosis
Fusar
12 2008 58 M Liver cirrhosis Trich
13 2009 64 F Lung cancer receiving
chemotherapy
Rhod
14 2009 68 F Hepatoma, liver cirrhosis Crypt
15 2009 83 F Colon cancer Trich
16 2010 70 M Diabetes mellitus, lymphoma
receiving chemotherapy
Crypt
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doi:10.1016/j.jmii.2012.01.013interesting, non-Candida fungal bloodstream infections also
deserve research. Therefore, we performed this study to
investigate the clinical significance of non-Candida isolates
causing fungemia.
The database of the Microbiology Laboratory of Chi Mei
Medical Center, Liouying branch, was searched for blood
cultures positive for non-Candida fungi from January 2005
to December 2010. The clinical charts of all patients
included in this study were retrospectively reviewed.
Information was collected on age, gender, and underlyingfungemia
al species Treatment In-hospital
mortality
tococcus laurentii Fluconazole No
ococcus neoformans Fluconazole No
ococcus neoformans Amphotericin B without
removal of catheter
Yes
ococcus neoformans Amphotericin B without
removal of catheter
Yes
ococcus neoformans Amphotericin B without
removal of catheter
Yes
ococcus neoformans Nil Yes
ococcus neoformans Nil Yes
ococcus neoformans Nil Yes
ococcus neoformans Fluconazole and removal
of catheter
No
ococcus neoformans Amphotericin B No
ium spp. Amphotericin B without
removal of catheter
No
osporon spp. Amphotericin B No
otorula spp. Fluconazole without
removal of catheter
Yes
ococcus neoformans Nil Yes
osporon spp. Fluconazole and removal
of catheter
No
ococcus neoformans Fluconazole without
removal of catheter
Yes
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Letter to the Editor 263immunocompromising conditions, including history of
immunosuppressant drug, diabetes mellitus, liver cirrhosis,
malignancy, and HIV infection.
During the study period, a total of 967 specimens from
428 patients had positive blood cultures for fungus. Based
on the number of patients with fungemia, the most prev-
alent species were Candida spp. (nZ 407, 95.1%), followed
by Cryptococcus spp. (n Z 12, 2.8%), Trichosporon spp.
(n Z 5, 1.2%), Fusarium spp. (n Z 2, 0.5%), Rhodotorula
spp. (n Z 1, 0.2%), and Penicillium spp. (n Z 1, 0.2%).
After reviewing the associated history, true non-Candida
spp. fungemia was confirmed in 16 patients, and transient
fungemia due to non-Candida species was diagnosed in
five patients. The clinical features of 16 patients with
non-Candida species bloodstream infections are summa-
rized in Table 1. The mean  standard deviation age was
63.5  12.6 years, and most of the patients (nZ 15, 93.8%)
had underlying diseases. Cancer was the most common
underlying disease (solid cancer, n Z 7; hematological
cancer, n Z 4). Diabetes mellitus and liver cirrhosis were
the second most common underlying diseases, follow by HIV
infection (nZ 2). Although the antifungal treatments were
various, in-hospital mortality developed in more than half
of the patients.
In the present work, there were several significant
findings. First, Candida spp. remains the most common
fungal agent causing bloodstream infection, consistent with
previous studies.2,3 Second, most of the patients with fun-
gemia due to non-Candida species had underlying immu-
nocompromised conditions, especially cancer. This suggests
that physicians should keep alert to these invasive fungal
infections in this era of a growing population of immuno-
suppressed patients.4 Third, among 12 patients with cryp-
tococcemia, the mortality was as high as 75%, which may be
attributed to two reasons: diagnosis of cryptococcemia was
not made before four patients die; and most of the patients
in this series had cancer.
This retrospective study had two notable limitations.
Because of the rarity of these unusual fungal infections, the
number of the patients was small and may not be gener-
alized to other hospital in Taiwan. Additionally, we did
not perform molecular identification and the in vitrosusceptibility to antifungal agents. Both of these deficits
still need further large-scale study with advanced labora-
tory methods.
In conclusion, although non-Candida fungemia is a rare
clinical entity, it can develop in immunocompromised
patients, and result in poor outcome.References
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